Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-10-26 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) −3,910 1,435,555
2022-10-25 Schlanger David J Executive Chairman Exercise or conversion +25,989 $0.91 $24K 108,537
2022-10-25 Schlanger David J Executive Chairman Sale −18,500 $39.48 $730K 90,037
2022-10-25 Schlanger David J Executive Chairman Sale −7,489 $39.98 $299K 82,548
2022-10-25 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) −25,989 1,358,680
2022-10-25 Livingston Mark S. CHIEF FINANCIAL OFFICER Shares withheld for taxes −226 $38.22 $9K 78,953
2022-10-25 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +32,000 $3.95 $126K 282,445
2022-10-25 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −23,154 $39.51 $915K 259,291
2022-10-25 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −8,846 $39.99 $354K 250,445
2022-10-25 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −5,787 $39.51 $229K 179,788
2022-10-25 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −2,213 $39.99 $88K 177,575
2022-10-25 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −2,385 $41.27 $98K 251,570
2022-10-25 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) −32,000 1,439,465
2022-10-24 Payson Norman Director Grant or award +3,480 12,132
2022-10-24 Payson Norman Director Grant or award · Stock Option (Right to Buy) +15,080 15,080
2022-10-24 SEIDENBERG BETH C Director Grant or award +4,060 14,154
2022-10-24 SEIDENBERG BETH C Director Grant or award · Stock Option (Right to Buy) +16,820 16,820
2022-10-24 SEIDENBERG BETH C Director Grant or award · Stock Option (Right to Buy) +1,898 1,898
2022-10-24 Dean Lloyd H Director Grant or award +2,900 2,900
2022-10-24 Dean Lloyd H Director Grant or award · Stock Option (Right to Buy) +14,500 14,500

Page 38 of 77 · 1,524 trades